AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11589718
Drug: Loop diuretic
RxNorm normalized name: Loop diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loop diuretic plus Thiazide diuretic (LD plus TD)
Trial: 9716148
Drug: routine detection
RxNorm normalized name: alpha tocopherol / ascorbic acid / cholecalciferol / docosahexaenoic acid / docusate sodium / ferrous fumarate / folic acid / pyridoxine hydrochloride / tricalcium phosphate Oral Capsule [Nexa Select]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: routine detection of LA antibodies
Trial: 7983959
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (n = 114)
Trial: 970902
Drug: Furosemide prophylaxis
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide prophylaxis (20-60 mg) in LPG
Trial: 28369381
Drug: Maraviroc 300
RxNorm normalized name: maraviroc 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maraviroc 300 mg twice daily
Trial: 8464952
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg DMI
Trial: 8464952
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg DMI
Trial: 3511767
Drug: Epidural buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural buprenorphine 0.3 mg
Trial: 22254076
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 400 µg/day
Trial: 25292137
Drug: D-dimer >
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-dimer > 0.987 mcg/ml and swelling > 1.5 cm of shin
Trial: 22378727
Drug: Plant sterol
RxNorm normalized name: plant sterol complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant sterol (PS) supplementation (1.6 g daily for 4 weeks)
Trial: 17505700
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral contraceptive (15 microg ethinyl estradiol/60 microg gestodene)
Trial: 11932759
Drug: 8-month regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-month regimen of anti-tuberculous drugs (NTCP recommended)
Trial: 11932759
Drug: 6-month regimen
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month regimen of anti-tuberculous drugs
Trial: 9617982
Drug: Sibutramine 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 30 mg
Trial: 9617982
Drug: Dextroamphetamine (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine (both doses)
Trial: 30293457
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (conventional exercise therapy)
Trial: 23008177
Drug: PCI using
RxNorm normalized name: PCI-27483
DrugBank: PCI-27483 (DB13000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCI using bare metal or drug-eluting stents (control arm)
Trial: 16733496
Drug: Budesonide 9
RxNorm normalized name: budesonide 9 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 9 mg/day (group A)
Trial: 16733496
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 10 mg/day (group B)
Trial: 11379400
Drug: Epoetin alpha
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin alpha (10,000 U subcutaneously, thrice weekly)
Trial: 7955813
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg felbamate twice a day
Trial: 7955813
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg felbamate twice a day
Trial: 7955813
Drug: Coadministration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministration of felbamate (600 mg and 1200 mg)
Trial: 3653463
Drug: Tolerance of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolerance of treatments
Trial: 25675558
Drug: Medication (nimodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (nimodipine and fluoxetine)
Trial: 23754711
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg/day for 6 weeks
Trial: 11037003
Drug: EGb 761
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGb 761 (ginkgo) 240 mg/day or 160 mg/day
Trial: 19501439
Drug: Darbepoetin alfa
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Darbepoetin alfa to increase hemoglobin levels to 13 g/dL
Trial: 10232440
Drug: Bronchial provocation
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bronchial provocation with lysine-aspirin
Trial: 10172710
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 1500 to 2000 micrograms via pressurized metered-dose inhaler with spacer
Trial: 6088252
Drug: Cimetidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (200 mg)
Trial: 25286913
Drug: Hemodynamically guided
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemodynamically guided HF management using daily uploaded pressures
Trial: 22311517
Drug: PTH(1‐34) infusion
RxNorm normalized name: PTH
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: PTH(1‐34) infusion
Trial: 20835586
Drug: Multiple-dose inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose inhaler (400 µg of MF once a day for 60 days)
Trial: 20835586
Drug: Single-dose inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose inhaler (400 µg of MF once a day for 60 days)
Trial: 16076379
Drug: Sevelamer 6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevelamer 6.0 g/day (Group A)
Trial: 16076379
Drug: Sevelamer 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevelamer 3.0 g/day and Calcium Carbonate 3.0 g/day (Group B)
Trial: 16076379
Drug: Calcium Carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium Carbonate 3.0 g/day (Group C)
Trial: 19401423
Drug: Rosiglitazone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone treatment
Trial: 10450630
Drug: Full Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full Cognitive Therapy (FCT)
Trial: 10450630
Drug: Brief Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief Cognitive Therapy (BCT)
Trial: 17719303
Drug: Sodium chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium chloride plus oral NAC (600 mg bid)
Trial: 15212623
Drug: Strontium ranelate
RxNorm normalized name: Strontium ranelate
DrugBank: Strontium ranelate (DB09267)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Strontium ranelate 1000 mg/day
Trial: 15212623
Drug: Strontium ranelate
RxNorm normalized name: Strontium ranelate
DrugBank: Strontium ranelate (DB09267)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Strontium ranelate 2000 mg/day
Trial: 15212623
Drug: Strontium ranelate
RxNorm normalized name: Strontium ranelate
DrugBank: Strontium ranelate (DB09267)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Strontium ranelate 2000 mg
Trial: 11456285
Drug: Glycine 5
RxNorm normalized name: glycine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycine 5 g orally
Trial: 3044870
Drug: Flurbiprofen (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen (300 mg: 100 mg twice a day orally and 100 mg suppository at night)
Trial: 3044870
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (75 mg: 25 mg twice daily orally and 25 mg suppository at night)
Trial: 29488900
Drug: Sublingual nitroglycerine
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerine (0.4 mg)
Trial: 21951683
Drug: Autologous peripheral
RxNorm normalized name: Autologous peripheral blood-derived CD34+ cells
DrugBank: Autologous peripheral blood-derived CD34+ cells (DB16367)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous peripheral blood stem cell transplantation (ASCT) after high-dose cyclophosphamide and busulfan
Trial: 21951683
Drug: Intensive chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chemotherapy with etoposide and mitoxantrone
Trial: 8705395
Drug: rBPI23 administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rBPI23 administered as a 5 or 30 min infusion at doses of 0.1 to 1 mg/kg
Trial: 1510645
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg, twice daily)
Trial: 30415354
Drug: Amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 500 mg capsule orally before RYGB surgery
Trial: 30415354
Drug: Amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 500 mg capsule orally 2 months after RYGB surgery
Trial: 30415354
Drug: Amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 500 mg capsule orally before and after RYGB surgery
Trial: 2507265
Drug: Insulin plus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin plus placebo
Trial: 1954640
Drug: Placebo (vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vehicle cream)
Trial: 22520141
Drug: Pentavalent rotavirus
RxNorm normalized name: Vaccine product containing only live pentavalent Rotavirus antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentavalent rotavirus vaccine (PRV), RotaTeq(®), 3 doses at approximately 6, 10, and 14 weeks of age
Trial: 20080470
Drug: Intensive use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive use of lotion containing 3% urea, polidocanol, and hyaluronic acid
Trial: 20080470
Drug: Standard use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard use of lotion containing 3% urea, polidocanol, and hyaluronic acid
Trial: 10981168
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II receptor blockers
Trial: 18595261
Drug: Long‐acting calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long‐acting calcium antagonists
Trial: 15751264
Drug: Combined hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined hormone therapy (estrogen-progestin)
Trial: 15751264
Drug: Other treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other treatment arms of the WHI (not specified)
Trial: 1087732
Drug: Intravenous L-5-hydroxytryptophan
RxNorm normalized name: L-5-HTP
DrugBank: Oxitriptan (DB02959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous L-5-hydroxytryptophan (L-5HTP)
Trial: 27091535
Drug: Guided Internet‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided Internet‐based cognitive behavioral therapy for insomnia (ICBT‐i)
Trial: 27091535
Drug: Active control
RxNorm normalized name: Accu-Chek Active Control Solution
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active control treatment (ICBT‐ctrl)
Trial: 15794787
Drug: Oral desmopressin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral desmopressin 400 microg
Trial: 8784652
Drug: Zalospirone 45
RxNorm normalized name: Tandospirone
DrugBank: Tandospirone (DB12833)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zalospirone 45 mg/day
Trial: 8784652
Drug: Zalospirone 6
RxNorm normalized name: Tandospirone
DrugBank: Tandospirone (DB12833)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zalospirone 6 mg/day
Trial: 8784652
Drug: Zalospirone 15
RxNorm normalized name: Tandospirone
DrugBank: Tandospirone (DB12833)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zalospirone 15 mg/day
Trial: 6467858
Drug: Sodium fluoride
RxNorm normalized name: Sodium Fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium fluoride (50 mg/day) combined with 25-50 micrograms of 25 OH cholecalciferol (calcifediol) per day for 6-18 months (12 patients) and 31-58 months (9 patients)
Trial: 24112635
Drug: Intravitreal 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal 0.5 mg ranibizumab
Trial: 22834417
Drug: Estradiol (E2)
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol (E2) gel 1.5 mg and oral micronized progesterone (P) 200 mg/day for the last 14 days of each cycle
Trial: 22834417
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated equine estrogens (CEE) 0.625 mg and oral medroxyprogesterone acetate (MPA) 5 mg for the last 14 days of each cycle
Trial: 16099600
Drug: Balsalazide (2250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balsalazide (2250 mg, twice daily for 5 days before RT and 2 weeks after completion)
Trial: 16099600
Drug: Placebo (identical-appearing,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical-appearing, twice daily for 5 days before RT and 2 weeks after completion)
Trial: 10872898
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1 g/day)
Trial: 10545746
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplement (100 mg orally daily) in addition to RRT
Trial: 3615572
Drug: Zuclopenthixol (37
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zuclopenthixol (37 mg daily)
Trial: 3615572
Drug: Perphenazine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perphenazine (30 mg daily)
Trial: 23734840
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g mesalazine suppository once daily for 4 weeks
Trial: 23734840
Drug: Placebo suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo suppository once daily for 4 weeks
Trial: 23734840
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g mesalazine suppository
Trial: 18420315
Drug: 11-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11-valent pneumococcal conjugate vaccine with protein D of Haemophilus influenzae as a carrier (PncPD11)
Trial: 18420315
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine (PncCRM7)
Trial: 12017793
Drug: Dentin bonding
RxNorm normalized name: SKIN BOND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dentin bonding agent alone
Trial: 12017793
Drug: Dentin bonding
RxNorm normalized name: SKIN BOND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dentin bonding agent in combination with flowable composite
Trial: 7678686
Drug: Cibenzoline (130-390
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cibenzoline (130-390 mg/day)
Trial: 7678686
Drug: Sotalol (160-320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol (160-320 mg/day)
Trial: 11838820
Drug: Placebo (placebo-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (placebo-controlled discontinuation study)
Trial: 27461787
Drug: Liposomal bupivacaine
RxNorm normalized name: bupivacaine liposome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal bupivacaine (4.0 mL buccal infiltration)
Trial: 27461787
Drug: Bupivacaine (4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (4.0 mL buccal infiltration)
Trial: 22549509
Drug: 930 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 930 mg/d choline intake
Trial: 22549509
Drug: 480 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 480 mg/d choline intake
Trial: 17683643
Drug: Litebook LED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Litebook LED treatment device (1,350 lux white light, spectral peaks at 464 nm and 564 nm) for 30 minutes a day upon awakening and prior to 8 A.M.
Trial: 17683643
Drug: Litebook LED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Litebook LED treatment device
Trial: 11926786
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of sildenafil plus inhaled iloprost
Trial: 11926786
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg of sildenafil plus inhaled iloprost
Trial: 9855514
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of sildenafil
Trial: 11926786
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg of sildenafil
Trial: 11926786
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of sildenafil plus iloprost
Trial: 9788422
Drug: NSAID (Voltaren
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAID (Voltaren resinat 2 x 75 mg/day for 2 weeks)
Trial: 7649965
Drug: Involvement in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Involvement in drug research
Trial: 15228261
Drug: 10 microg
RxNorm normalized name: Estradiol 10 microgram vaginal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 microg of leishmanial protein in the alum-precipitated ALM + BCG vaccine mixture
Trial: 15228261
Drug: 100 microg
RxNorm normalized name: Digoxin 100 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 microg of leishmanial protein in the alum-precipitated ALM + BCG vaccine mixture
Trial: 15228261
Drug: 200 microg
RxNorm normalized name: Digoxin 200 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg of leishmanial protein in the alum-precipitated ALM + BCG vaccine mixture
Trial: 15228261
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg of leishmanial protein in the alum-precipitated ALM + BCG vaccine mixture
Trial: 15228261
Drug: Alum-precipitated ALM
RxNorm normalized name: Precipitated Sulfur
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alum-precipitated ALM + BCG vaccine mixture
Trial: 9074719
Drug: Heparin (1,250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (1,250 IU x 2/SC/day for 30 days)
Trial: 6350097
Drug: Cimetidine, 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine, 1200 mg daily
Trial: 6350097
Drug: Antacid (Mylanta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid (Mylanta II, 7 oz daily)
Trial: 21160466
Drug: Nicotine patches
RxNorm normalized name: NICOTINE 7 mg in 1 g TRANSDERMAL PATCH [Sielkin QUIT SMOKING NICOTINE PATCHES]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patches combined with paired associative stimulation (PAS)
Trial: 21160466
Drug: Nicotine patches
RxNorm normalized name: NICOTINE 7 mg in 1 g TRANSDERMAL PATCH [Sielkin QUIT SMOKING NICOTINE PATCHES]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patches combined with transcranial direct current stimulation (tDCS)
Trial: 21160466
Drug: Placebo patches
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patches combined with paired associative stimulation (PAS)
Trial: 21160466
Drug: Placebo patches
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patches combined with transcranial direct current stimulation (tDCS)
Trial: 19383242
Drug: Enteric-coated diclofenac
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Enteric-coated diclofenac 50 mg, administered orally three times daily for 2 weeks prior to surgery
Trial: 19383242
Drug: Rofecoxib 12.5
RxNorm normalized name: rofecoxib 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 12.5 mg, administered orally three times daily for 2 weeks prior to surgery
Trial: 19383242
Drug: Placebo, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, administered orally three times daily for 2 weeks prior to surgery
Trial: 9573535
Drug: Lowest tertile
RxNorm normalized name: textiles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lowest tertile (UProt < 1.9 g/24 hr)
Trial: 9573535
Drug: Middle tertile
RxNorm normalized name: wheat middlings extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Middle tertile (UProt 2.0 to 3.8 g/24 hr)
Trial: 9573535
Drug: Highest tertile
RxNorm normalized name: textiles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highest tertile (UProt 3.9 to 18.8 g/24 hr)
Trial: 8159037
Drug: Aspirin 300
RxNorm normalized name: aspirin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 300 mg thrice daily plus dipyridamole 75 mg thrice daily